UBS Group’s Clene Inc Warrant CLNNW Stock Holding History

UBS Group’s Portfolio CLNNW Stock Details CLNNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,309	Closed	-$29	–	10385
2025 Q2	$29	Sell	1,309 -1,361	-51%	-$45	﹤0.01%	10094
2025 Q1	$85	Hold	2,670	–	–	﹤0.01%	9961
2024 Q4	$134	Sell	2,670 -4,956	-65%	-$203	﹤0.01%	9616
2024 Q3	$252	Buy	7,626 +4,286	+128%	+$164	﹤0.01%	9038
2024 Q2	$104	Buy	+3,340	New	+$151	﹤0.01%	9155
2023 Q1	–	Sell	-5,995	Closed	-$180	–	9668
2022 Q4	$180	Buy	+5,995	New	+$418	﹤0.01%	10331
2021 Q4	–	Sell	-197	Closed	–	–	10293
2021 Q3	$0	Sell	197 -230	-54%	-$256	﹤0.01%	9587
2021 Q2	$1K	Sell	427 -998	-70%	-$1.01K	﹤0.01%	9133
2021 Q1	$2K	Buy	+1,425	New	+$1.65K	﹤0.01%	8600

Other funds holding CLNNW

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's CLNNW Position: Q3 2025 in Review

UBS Group sold out of Clene Inc Warrant (CLNNW) in Q3 2025, closing a stake of 1,309 shares — an estimated $29 sold.

UBS Group first reported a position in CLNNW in Q1 2021 and held it in 9 quarters. The position peaked at $2K in Q1 2021. 4 funds tracked by Wall St. Rank hold CLNNW as of Q3 2025.

UBS Group reported no remaining Clene Inc Warrant position as of Q3 2025 after selling out during the quarter.
UBS Group sold 1,309 Clene Inc Warrant shares in Q3 2025, an estimated $29.
UBS Group first reported a position in Clene Inc Warrant in Q1 2021 and held it in 9 quarters.
UBS Group's Clene Inc Warrant position peaked at $2K in Q1 2021.
4 funds tracked by Wall St. Rank held Clene Inc Warrant as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.